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Much of the science underpinning the global response to the COVID-19 pandemic lies in the soft
matter domain. Coronaviruses are composite particles with a core of nucleic acids complexed to
proteins surrounded by a protein-studded lipid bilayer shell. A dominant route for transmission
is via air-borne aerosols and droplets. Viral interaction with polymeric body fluids, particularly
mucus, and cell membranes control their infectivity, while their interaction with skin and artificial
surfaces underpins cleaning and disinfection and the efficacy of masks and other personal pro-
tective equipment. The global response to COVID-19 has highlighted gaps in the soft matter
knowledge base. We survey these gaps and suggest questions that can (and need to) be tackled,
both in response to COVID-19 and to better prepare for future viral pandemics.
The coronavirus disease 2019 (COVID-19) pandemic caused by
the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2)1 has focussed unprecedented attention on science and technol-
ogy. Fighting a pandemic is, at first sight, a challenge principally
for biotechnology and the biomedical sciences, which have indeed
responded rapidly: witness, for example, the speed at which can-
didate vaccines have been brought to clinical trial. However, the
reality is that effort from many disciplines is needed to respond
adequately to the pandemic. Thus, the sudden need for extra ven-
tilators has brought innovative solutions from engineering design
and manufacturing. Ventilation is only one aspect of the fluid
dynamics needed to confront COVID-19. Other fluid dynamical
aspects of the disease, such as the aerodynamics of aerosol trans-
port, have recently been revealed.2
Coronaviruses belong to the family of ‘enveloped viruses’. An
enveloped virus has a lipid bilayer ‘shell’ with embedded proteins
enclosing a ’core’ consisting of nucleic acids complexed with pro-
teins.3 It is therefore a ‘quintessential soft matter object’: a com-
posite colloid made up of surfactants and polymers. Respiratory
coronaviruses such as SARS-CoV-2 are transmitted4 by another
kind of soft matter object, aerosols in which the liquid phase is
rich in mucin and other biopolymers. Here, we survey some of
the soft matter science that is relevant to COVID-19, paying par-
ticular attention to gaps in the knowledge base. In doing so, we
also want to provide entry points into a diverse literature, but
with no claim to completeness. The review already cited2, a criti-
cal compilation of numerical data,5 an overview of the challenges
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presented to physical scientists and engineers by COVID-19,6 and
a survey of nanotechnological responses to the pandemic7 are
also useful sources of references.
The soft matter science of SARS-CoV-2 falls naturally under two
headings: how the virus invades the body, and how infection is
spread. Both stories start with a virus on the surface of the respi-
ratory tract, Fig. 1(a). The epithelia of our respiratory,8 gastroin-
testinal and reproductive tracts are covered by viscoelastic mucus.
Its composition varies with site, time and state of health, but the
most important macromolecular components are high molecular
weight mucin proteins and DNA shed from cell debris.9,10
The ‘inside’ story of viral transmission starts with a virus land-
ing on a mucosal surface.11 It then has to diffuse through12–14
a highly heterogeneous viscoelastic porous medium.9,13 This in-
volves the generic physics of nanoparticle diffusion in soft porous
media15 and the more specific physics of adhesive receptor-ligand
binding, both of which are also relevant for designing synthetic
nanoparticles for drug delivery.16 As far as adhesion is concerned,
bacteria behave as colloids with sticky patches, and show signifi-
cant phenotypic heterogeneity.17 On statistical grounds, it seems
likely that the distribution of sticky moieties is also patchy on
enveloped viruses, so that considering them as patchy nanopar-
ticles18 may provide new insights, e.g. concerning wettability,19
which may influence mucosal penetration. Virions that succeed
in diffusing through the mucus then face an osmotic permeability
barrier due to mucins tethered to epithelial cells.20
Beyond this first stage of mucosal penetration, the ‘inside’ story
rapidly becomes dominated by specific virus-cell interactions. For
the rest of this essay, we will focus instead on the ‘outside’ story of
SARS-CoV-2, where biologically specific interactions play less of a
role. We will first discuss the soft matter science of SARS-CoV-2
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transmision and of protecting ourselves against the virus, Fig. 1.
Two briefer sections then survey how the virus or infection can
be detected and the sustainability issues raised by COVID-19. We
end with a general discussion and some concluding remarks.
1 Transmission
Airborne transmission is the dominant route for the spread of
COVID-19.4 A simplified schematic of some of the components of
airborne transmission is shown in Fig. 1. What is immediately ob-
vious is that a challenging range of length scales is involved. Soft
matter scientists deal regularly with such multi-scale problems,
because soft matter inhabits the ‘middle world’ that bridges the
microscopic and the macroscopic.21 In terms of the average diam-
eter of a coronavirus∗ D≈ 100nm, the relevant length scales span
from ∼ 10−2D (individual coat proteins) through 102D (fabric mi-
crostructure) to 107D (macroscopic air flow). More implicit, but
no less challenging, is the range of relevant time scales, spanning
from the Brownian time of a single virus in water (time taken to
diffuse its own diameter), τB . 1ms, through the ∼ 104τB needed
for 0.1mm droplets to evaporate completely in air23,24 and the
. 105τB for virus-cell fusion processes,25 to the & 109τB (weeks)
taken by COVID-19 to run its course in humans.26
1.1 Air-borne droplets
Respiratory viruses are transmitted from human to human either
via the air or via contact, the latter either directly via an infected
individual or indirectly via a contaminated surface.27 Virus-
bearing mucus is brought up and expelled as smaller ‘aerosols’
or larger ‘droplets’ when an individual exhales, speaks, coughs or
sneezes, Fig. 1(a). The distinction between aerosols and droplets†
originated with W. F. Wells’ 1934 work that studied the fate of wa-
ter drops in air. He proposed a crossover diameter below which
a drop would completely evaporate before it fell to the ground,
while a bigger drop would hit the ground before it had completely
evaporated.23 This crossover clearly depends on the initial height
at which the drop is released, its initial motion, and the relative
humidity of the air. The original estimate23 of . 200µm has been
revised down,24 and in the current virology literature is often
taken to be ≈ 5µm (see, e.g., Zhou et al.29). We will see shortly
that this ‘one-body’ picture does not capture the complexity of
the real situation. We will therefore not make the aerosol/droplet
distinction, and use the word ‘droplet’ as a generic term covering
all sizes, mentioning the diameter explicitly if it is relevant. Using
the term in this sense, we learn from a study of the the droplets
produced by coughing30 that the size distribution spans a wide
range, from ≈ 0.6 to ≈ 16µm, with a mode of around 6 µm.
Respiratory droplets expelled by infectious individuals can be
directly inhaled by another person or deposited on surfaces, ei-
ther on another person or on environmental objects (which, inso-
far as they carry infection, are known as ‘fomites’); anyone touch-
∗The size and shape of viruses is phenotypically heterogeneous, and the heterogeneity
may be an adaptive trait. 22
† In some aerosol science literature, what we call ‘aerosols’ here are called ‘droplet
nuclei’, and both droplets and droplet nuclei are known as aerosols. 28
ing fomites and then the mucous membranes of their own eyes,
noses or mouths may become infected.
The droplets ejected by sneezing, etc.2,31,32 contain mature vi-
ral particles, or virions dispersed in a solution of inorganic salts
(NaCl, etc.), surfactants (lipids), mucins, and probably other
biopolymers,33 Fig. 1(c). This compositional complexity is im-
portant. For example, the presence of mucin is known to improve
the survivability of the H1N1 flu virus in aerosols and droplets,34
rendering it more or less independent of the relative humidity of
the environment.35 To underline this compositional complexity,
we will speak of biopolymer-lipid-salt-virion (BLSV, pronounced
‘BiLi-SaVi’) droplets and deposits on surfaces.
Intuitively, one may imagine that virus bearing material is
ejected by infected individuals as already-formed droplets – in-
deed, we have seen that this ‘one-body’ picture lies behind the dis-
tinction between ‘aerosols’ and ‘droplets’. However, recent fluid
dynamical work2,31,32 shows that at least in sneezing, respiratory
droplets are not primarily ejected ‘as formed’, but are the result
of multiple fragmentation processes post-ejection. It is known
that in Newtonian fluids, particles, even when present at low di-
lution, can decisively influence the kinetics of jet and sheet frag-
mentation (see Lindner et al.36 and references therein for jets and
Raux et al.37 for sheets), although the distribution of particles in
the resulting population of droplets has not, to our knowledge,
been studied. Moreover, threadlike structures observed in sneeze
ejecta32 implicate high-molecular-weight mucins, because such
threads are characteristic of fluids with significant elasticity.38
Importantly, it is not so much the ‘single-body’ motion of isolated
droplets but the collective motion of a propelled turbulent cloud
of droplets that controls subsequent deposition on surfaces.2,31,32
A recent article entitled ’COVID-19 by the numbers’5 has high-
lighted the importance of quantification. A good first question
for a quantitative soft-matter approach to SARS-CoV-2 transmis-
sion is: how many viruses are there per droplet? A study of the
distribution of virus numbers in aerosols artificially generated by
nebulisation39 finds concentrations that extrapolate to about one
virion per ∼ 1µm droplet.‡ Other studies have found that the
majority of droplets carrying influenza viruses may be . 5µm in
diameter (see Bischoff et al.40 and references therein), while a
very recent preprint on SARS-CoV-2 in hospital environments41
reports a more variable picture, even though in some cases, the vi-
ral load is still concentrated in small (in this case. 1µm) droplets.
However, there appears to be no measurement of viral titre
in individual human respiratory droplets. Nevertheless, the fig-
ure of ‘100,000 to 1,000,000 virions per droplet’ for the flu virus
is widely quoted.42 As we will see shortly, this figure is wildly
unlikely. It possibly originated as an estimated upper bound
based on maximum packing:43 a 10 µm droplet can contain up
to ∼ (10/0.1)3 = 106 particles of 0.1µm diameter, corresponding
to a viral volume fraction of φv∼ 1 (or, more exactly, random close
packing, φv . 0.64).
‡However, this and similar studies involve nebulising virions using Newtonian aque-
ous solutions and therefore do not reproduce the mucoidal ejecta from which real-
life droplets are generated.
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Fig. 1 Schematic of some of the soft matter science in virus transmission (not to scale!). (a) Virus particles (black) are presented on or in the mucus
lining of internal epithelia (red). (b) Droplets of virus-bearing mucus are ejected via coughing, sneezing, breathing or talking. (c) A coronavirus with
RNA surrounded by a lipid bilayer in which are embedded various proteins. (d) Droplets landing on surfaces will dry while exposed to air. (e) The
final result is adsorbed viral particles, individual or clustered, each presumably with residual mucosal biopolymers, lipids and salts. Hands touching
such surfaces may pick up virions and spread infection. (f) A droplet impinges onto a face mask, whose microstructure is a network of polymer fibres;
these trap droplets, which then dry to leave adsorbed viruses, again complexed with biopolymers, lipids and salts. (g) Air flow (breathing) or liquid flow
(e.g. washing) through this complex porous medium determines its effectiveness and susceptibility to cleaning.
For an evidence-based estimate, we turn to a recent measure-
ment of the concentration of the viral load in the sputum of
hospitalised patients with COVID-19.26 This study found that
the average viral titre was ≈ 7×106ml−1, with a maximum of
≈ 2×109ml−1. Another recent study of the saliva of COVID-19
patients found loads of. 106ml−1 within a week of onset of symp-
toms, and a peak load of . 109ml−1 in a number of patients in
their early 60s.44 Using a virion diameter of 100 nm, the maxi-
mum load from the sputum study translates to φv ≈ 10−6. If such
sputum is entirely turned into 5 µm droplets and the viral load is
distributed uniformly, then we expect the mean number of virions
per droplet to be ∼ 0.1. If a Poisson distribution applies, then the
number of 5 µm droplets with 0, 1, and 2 virions will be in the
ratio 200:20:1, so that ≈ 1% of 5 µm droplets will contain (single)
virions, and only 0.55% of the droplets will have ≥ 3 virions.§
A method for measuring the viral titre in respiratory droplets in
situ will clearly enable more precision in this matter. Meanwhile,
we should put our estimates in the context of two other statistics.
First, a cough or talking for 5 minutes can generate ∼ 3× 103
droplets, while a sneeze can generate . 4×104 (see the review by
Cole and Cook45 and references therein). Secondly, The (strain-
§ Note, however, that since particles affect ejecta fragmentation, the distribution of
particles in droplets will probably not be uniform.
dependent) minimum infective dose (MID)¶ of the flu virus is
typically a few thousand virions for influenza.46
The next soft matter question is: where are the virions in the
respiratory droplets? The answer is poorly known at present.33 A
100 nm virus takes only ≈ 1s to diffuse from the centre of a 10 µm
water droplet to its surface. A virus or indeed any other particle
approaching an air-water interface may become bound to the in-
terface, with or without breaching it. The outcome depends on
the salt concentration and the details of the particle surface.47,48
The observation of non-monotonic dependence of both the mag-
nitude and sign of the particle-interface interaction on salt con-
centration47 is particularly interesting, because this variable con-
tinuously increases as the droplet evaporates in transit and on
surfaces. If virions do breach the air-water interface, then they
may be subjected to strong interfacial forces (see Section 1.3).
The final cluster of questions is about evaporation. BLSV
droplets start to evaporate immediately upon release into the air.
A study using environmental chambers finds that the viability of
bacteriophages suspended in droplets of growth media (salts +
small molecule metabolites) shows a non-monotonic dependence
on the relative humidity, displaying a pronounced minimum in
viability at intermediate relative humidity.49 The authors suggest
¶The minimum dose needed to cause infection in 50% of individuals.
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that this is because viral survival depends on the product of solute
concentration and time. In other words, the evaporation kinetics
of droplets matters.
The evaporation kinetics of droplets of 300 nm silica particles
in salt solution deposited on porous superhydrophobic surfaces
(to mimic airborne droplet conditions50) was found to depend
strongly on both salt and colloid concentration.51 The latter is
likely very low in respiratory droplets according to our previous
discussion of viral titre, so it is the biopolymer-lipid-salt solutes
that will determine the evaporative kinetics of such droplets. A
recent study of model BLSV droplets suggests that concentra-
tion and pH changes during in-transit evaporation may lead to
a core-shell structure and/or induce mucin gelation.33 The de-
velopment of such structure will undoubtedly affect drying kinet-
ics, as well as how such droplets impact environmental surfaces
(see next section). It will also control, ultimately, the structure of
the encrusted virions – composite BLSV particles – left behind on
fomites, which, in turn, may affect viral survival.
1.2 Droplet-surface interaction
After expulsion from the body, BLSV droplets eventually impact
a variety of surfaces, which become potential sites for transmit-
ting infection,27 Fig. 1(e). The relevant questions for soft mat-
ter science in fomite transmission can be discussed under three
headings: impact, drying and removal. First, there is a need to
understand the initial impact of the droplets on surfaces. Sec-
ondly, after impact, the droplets dry to leave a deposit of virions;
so the kinetics of the drying process and the structure of the com-
posite BLSV particles left behind need to be elucidated and their
relevance for viral viability explored. Thirdly, these BLSV particles
can be removed by cleaning or picked up on skin. The underlying
mechanisms of these processes need to be understood.
The impact of Newtonian liquid droplets on hard surfaces has
been well studied.52 The effect of viscoelasticity in the droplet
has attracted recent attention, partly because of the ‘anti-rebound’
effect of high-molecular-weight polymeric additives.53,54 It is
clearly of interest to know if the mucus in respiratory droplets
bearing viruses also confers this property, and the possible effects
of mucin gelation. The possibility of structuring at the air-liquid
interface33 further complicates the likely behaviour at impact.
Post impact, droplets dry to leave BLSV particles on the surface,
Fig. 1(e). The drying of a dilute droplet of spherical colloids in
a Newtonian fluid on a featureless hard substrate is well under-
stood: it gives rise to a ‘coffee ring’ in which all the particles are
deposited at the rim.55 Gelation of the evaporating droplet56 or
surface-driven flows induced by the presence of surfactants57 can
inhibit coffee ring formation and lead to a more uniform deposit
of particles. Mucin gelation and/or the presence of lipids in res-
piratory viral droplets33 may have this effect. However, the small
size of virions may mean that they can freely diffuse in a mucin gel
network, and nullify the expected effect of gelation. Respiratory
droplets also contain salts. The drying of salt solution droplets
differs significantly from the drying of colloidal suspensions.58
How this is modified by the presence of lipids and biopolymers is
unknown. Note that there is a growing literature on the drying of
blood droplets aimed at forensic science and personal health ap-
plications.59,60 Since blood is a complex fluid of biological origin,
this literature may give additional insight into the drying of BLSV
droplets (e.g. the role of proteins).
The environmental surfaces that mucoidal viral droplets may
land on range from relative simple – a glass table top – to very
complex, such as a fabric mask surface, Fig. 1(f), or human skin,
where a network of microchannels controls surface fluid trans-
port.61 The study of drying on such patterned and/or ‘soft’ sur-
faces is an active area of soft matter research.62 Given the cocktail
of solutes, the final deposit on these simple or complex surfaces
after drying is complete will not be individual bare viruses, but
composite BLSV particles. The drying kinetics will determine the
structure of these composites.
Unsurprisingly, there exist many measurements of viral viability
on fomite surfaces63,64 If we look behind reported survival times
to the raw data,65,66 we repeatedly see that, once deposited, the
number of viable virus decreases according to n(t)= n0 exp [−t/t0],
but with wide variations in the actual value of t0 for different
virus-surface combinations. Currently, this time scale is simply
accepted as a ‘brute fact’ to be determined experimentally. So, for
example, for SARS-CoV-2, t0 ≈ 1 to 2 h on copper and ≈ 7 to 8 h on
plastics.66 However, the fact that there seems always to be a well-
defined, characteristic time scale irrespective of the specific virus
and surface is immediately striking for the physicist, suggesting
an (unknown) generic underlying mechanism.
Surface viability studies typically do not specify explicitly what
kind of droplets are being deposited. For example, in one descrip-
tion of experimental method, we read that viral aerosols ‘were
generated by passing air at a flow rate of 7.5 L/min through a 3-
jet Collison nebulizer’.67 One can only assume that this generated
droplets of viruses in aqueous (possibly isotonic saline) solutions.
It is not obvious that such studies should be relevant to the sur-
vival of viruses encrusted in biopolymers, lipids and salts, either
as individuals or in clusters. The presence of these moieties will
affect viral survival for a number of reasons.
First, ions are integrated into the structure of viral capsids, and
it is known that such ‘structural ions’ are important for prevent-
ing capsid collapse during the desiccation of the Triatoma virus
(TrV).68 Presumably the same applies more generally to other
viruses. Secondly, we may expect that biopolymers, lipids and
salts could help retain residual moisture and therefore change
the local absolute humidity (mass of water per unit volume of
air). Both the absolute69 and relative63,64 humidity are known
to affect viral survival. Much more work is clearly needed.
To complete the transmission cycle, we need, finally, to con-
sider surface-to-surface transfer.34 Many recent studies have mea-
sured the transfer of a variety of bacteria and viruses between
fomites and hands or cleaning cloths (see Zhao et al.70 and refer-
ences therein). Of the wide range of environmental factors stud-
ied, a few have very strong effects, e.g., for some bacteriophages,
humidity increases the rate of surface-to-hand transfer approxi-
mately threefold,71 perhaps pointing to a role for capillarity. Sur-
face roughness and porosity, the contact force, the direction of
transfer (hand to surface or vice versa), and the type of microor-
ganism are all also significant.70 The fundamental science under-
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lying transfer mechanisms appears to have been little studied to
date, much of which clearly lies in the soft matter domain.
1.3 Forces
During transmission, virions are subjected to forces of many
kinds. Thus, large capillary forces operate on the particles in the
final stages of the drying of a colloidal suspension when particles
poke out of the air-liquid interface. These lead to the deformation
and coalescence of latex particles,72 which, in paint, gives rise to
a (desirable) continuous film. The stresses involved are of order
σdry ∼ γ/R, where γ . 70mNm−1 is the surface tension of aque-
ous solutions while R. 100nm is a typical viral dimension, giving
σdry . MPa. Similar or larger forces operate when air ingresses
into a viral capsid in the final stages of desiccation, which may
break the capsids and/or eject the genetic material.73
Two other sources of forces may be relevant. First, as both nu-
cleic acids and proteins are charged, electrostatics is important
role in viral physics.74 It needs to be accounted for to understand
genome packaging,75 and it controls the osmotic pressure differ-
ential between the virion interior and the external medium.76
A simple estimate of the electrostatic self-energy of a viral cap-
sid, viewed as a protein shell of uniform charge density (which
can be as large as one electron per nm2), shows that this scales as
σ2(ε0ε)−1R2λ ;75 here R and σ are the capsid radius and surface
charge density respectively, λ is the Debye length, and ε0 and ε
are the permittivity of vacuum and the dielectric constant of the
medium. Using realistic numbers for RNA virions, we find self en-
ergies of ∼ 104kBT in physiological buffers (i.e., 150 mM mono-
valent salts such as NaCl), but the exact number is sensitive, for
instance, to the salt concentration in the local viral environment.
As virions self assemble, this self-energy needs to be balanced by
hydrophobic or van der Waals interactions, and varying salt con-
centration may be a way to tilt the balance towards assembly or
disassembly.75 These considerations suggest that the neglect of
electrostatics in modelling capillary effects during viral desicca-
tion73 may be unsafe. More generally, a systematic probing of
the role of electrostatics in BLSV droplets should be fruitful.
At first sight, forces from everyday flows are unlikely to be
strong enough to inactivate viruses. However, a number of long-
standing and intriguing observations suggest that there are sit-
uations in which this may not be so. When gases are bubbled
through a viral solution,77 or the solution is tumbled in a test
tube78 or flowed through a packed bed,79 viral deactivation en-
sues. It has long been known that colloids may partially or com-
pletely aggregate under mechanical agitation (stirring, etc.).80
However, coagulation per se does not need to affect viability, al-
though it can decrease the viral titre.81 Moreover, the tumbling
inactivation of bacteriophages did not apparently involve coag-
ulation.78 Instead, early experiments show conclusively that the
effect is due to viral particles becoming adsorbed at the air-water
interface.82 A 1948 paper suggests that once a virion is so ad-
sorbed, ‘it is subjected to such forces that it may very rapidly
be deprived of the property of infectivity’.77 The nature of these
forces has so far remained obscure. Given the importance of parti-
cles at interfaces to soft matter science,83–85 this is an area where
important progress can be expected.
The effect of forces can be studied directly using various kinds
of atomic force microscopy (AFM). So, for example, the contact
mechanics of brome mosaic viruses adsorbed on model substrates
(graphene and mica) has been measured.86 The strong forces at
the liquid-virus-substrate contact line can noticeably compress the
capsids, and allow the quantitation of capsid elasticity. Capsid
failure has also been studied by measuring the force-indentation
curve of individual virus particles.87 Such ‘mechanical virology’ is
a very active area of research88,89 in which soft matter scientists
should be able to make a strong contribution. Progress in viral
mechanics, coupled with an understanding of what forces operate
on viruses, especially at interfaces, should suggest strategies by
which virions may be mechanically inactivated.
1.4 Re-entry
For completeness, we mention that virus-bearing droplets de-
posited on fomite surfaces must gain entry to and infect a sus-
ceptible individual to complete the infection cycle. This is mostly
part of the ‘inside’ story, so that we will not discuss the matter
in detail. Suffice it to say that the rehydration of a substantially
desiccated BLSV composite particle and its wetting kinetics on a
mucus-covered epithelial surface will involve complex, and fasci-
nating, soft matter science and biological physics.
2 Protection and disinfection
2.1 Face masks
The wearing of face masks for health and safety has a long his-
tory. Pliny the Younger (died 79 C.E.) describes how ‘[p]ersons
polishing cinnabar in workshops tie on their face loose masks
of bladder-skin, to prevent their inhaling the dust in breathing,
which is very pernicious, and nevertheless to allow them to see
over the bladders’.90 The mask made from bladder – soft mat-
ter of living origin – evidently covered the whole face, but was
translucent enough for the wearer to retain adequate vision.
According to both field surveys91 and theoretical epidemio-
logical modelling92 published since the start of the current epi-
demic, the wearing of face masks may offer protection against
COVID-19 infection. The extent to which this is because the
wearing of masks reduces the release of respiratory droplets into
the air by infected individuals and/or reduces the inhalation of
such droplets by susceptible individuals is not clear. A very recent
Schlieren imaging study does, however, make it clear that wear-
ing various face coverings can significantly reduce the spatial ex-
tent of the frontal air flow ejected by a person while breathing or
coughing.93 We focus our discussion on fabric face masks.
These masks work by filtering out virus-bearing droplets,
Fig. 1(f). In America, the Center for Disease Control (CDC)
recommends the use of N95 grade masks for protecting against
SARS-CoV-2. N95 filter fabrics are certified according to a proto-
col set out by the CDC’s National Institute for Occupational Safety
and Health (NIOSH Document 42 CFR Part 84).94,95 NIOSH spec-
ifies that mask fabrics should be tested for their ability to filter
out, at an air flow rate of 85 litres per minute, NaCl aerosols (me-
dian diameter 75± 20nm, which presumably evaporate rapidly),
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and dioctyl phthalate aerosols (median diameter 185± 20nm) as
surrogates for solid particles and liquid drops respectively. To
qualify as N95 filter fabric, the aerosol concentration downstream
must be 5% of that upstream. The recommendation of N95 grade
masks in the current pandemic is presumably based on the twin
facts that the specified median NaCl aerosol size (75 nm) – the
surrogate for all solid particles – is somewhat smaller than the
virion diameter (100 nm), and that the specified dioctyl phtha-
later aerosol size (185 nm) is considerably smaller than the mode
of cough droplets (6 µm). (See also related discussion and further
references in Bar-On et al.5)
An important issue that has emerged as the pandemic crisis
progresses is whether face masks could be washed and reused.96
The potential soft matter science contribution to this issue is to
understand what happens when a BLSV droplet lands on a net-
work of (possibly charged) synthetic polymer fibres and subjected
first to humid air flow (wearer inhalation/exhalation) and then
to liquid flow and heat (washing), Fig. 1(g). To arrive at such an
understanding, we need progress on practically all of the areas
reviewed in Sections 1.2 and 1.3, and more. ‘More’ because, now,
there is a complex fibrous network to contend with. To take just
one of the new issues raised by this complex environment, the
study of liquid drops deposited on flexible fibre arrays is only in
its infancy.97 The combined action of heat and soaps on natural
or synthetic fibre structures also needs to be studied. Note in this
context that humidity has an important effect on the permeability
of fabric.98 The new physics of why fabric networks actually hold
together99 may also prove relevant here. The soft matter science
of mask cleaning is therefore wide open.
2.2 Sanitising
‘Every nurse ought to be careful to wash her hands very frequently
during the day. If her face too, so much the better,’ so says Flo-
rence Nightingale in her pioneering text published in 1859 based
on field experience during the Crimean War.100 Her prescient re-
marks, made just as Louis Pasteur was beginning his experiments
that led to the germ theory of infectious disease,101 are as rel-
evant today as they were one and a half centuries ago. A 1999
British Medical Journal editorial was entitled: ‘Hand Washing: A
modest measure – with big effects’,102 while a recent letter to
the editor of another journal during the COVID-19 crisis is en-
titled ‘Revisiting Nightingale’s legacy’.103 The World Health Or-
ganisation (WHO) agrees; one of their COVID-19 pamphlets104
is headlined ‘SAVE LIVES: CLEAN YOUR HANDS’, explaining that
‘COVID-19 virus primarily spreads through droplet and contact
transmission. Contact transmission means by touching infected
people and/or contaminated objects or surfaces. Thus, your
hands can spread virus to other surfaces and/or to your mouth,
nose or eyes if you touch them.’
Many aspects of the physical science of hand washing is un-
known. In fluid dynamics, for example, the authors of a recent
review2 article say, ‘Amazingly, despite the 170+ year history of
hand washing in medical hygiene, we were unable to find a sin-
gle published research article on the flow physics of hand wash-
ing.’ The ignorance is less stark when it comes to the soft mat-
ter science underpinning hand hygiene: there is a large relevant
background literature to form the basis of research specifically
targeted at SARS-CoV-2 and other respiratory viruses.
Hands can be sanitised against such viruses using different
chemical agents,63 the most common being surfactants and al-
cohols. A 2009 study found that, although both are efficacious to
varying degrees, washing hands with soap and water was superior
against the H1N1 influenza virus.105 Based on results from stud-
ies of sanitising hands against bacterial pathogens,106 the CDC
suggests107 that soap should also be more effective against SARS-
CoV-2 in non-clinical settings. In these settings, hands are more
likely to be soiled. Washing with soap is effective in removimg
grease and other forms of dirt, which can trap pathogens.
There are many studies of the action of surfactants on model
lipid bilayer systems such as giant unilamellar vesicles (GUVs),
some of which are directly inspired by the use of surfactants
as agents against enveloped viruses (e.g., in vaginal microbio-
cides108). A very recent preprint109 lists previous publications on
the antiviral action of commercial surfactant products, but these
and other studies report measurements of efficacy with little to
say about mechanism. Significantly, one study110 of the inacti-
vation of enveloped viruses by surfactin, a potent biosurfactant
from Bacillus subtilis, claims that ‘the antiviral action . . . seems to
be due to a physicochemical interaction of the membrane-active
surfactant with the virus lipid membrane.’ The words we have
italicised suggest that the relevant science is soft matter rather
than molecular biology.
One interesting example of a mechanistic study is of the inac-
tivation of human (H3N2) and avian (H5N3) influenza viruses
by potassium oleate (C18:1), sodium laureth sulfate (LES) and
sodium lauryl sulfate (SLS) using isothermal titration (ITC).111
It found that surfactant-virus interaction was exothermic for LES
but endothermic for the other two, with LES being the least effec-
tive inactivation agent, and C18:1 being the most effective. The
authors speculated on molecular mechanisms, suggesting, for ex-
ample, that there is strong electrostatic interaction between the
negative head group of C18:1 and the positively-charged hemag-
glutinin proteins embedded in the viral lipid envelope.112 Much
more work is needed, e.g., paying attention to the aggregation
state of the surfactants, before these suggestions can be confirmed
or refuted.
It is convenient to discuss another observation under the
heading of surfactants. Unsaturated fatty acids are known
to be effective in inactivating enveloped viruses (flu, SARS,
COVID-19, . . . ).113 However, the pKa of the moieties studied are
all around 9.5,114 so that at or around neutrality, these molecules
are fatty acid oils and not surfactants. Their action must be more
subtle, and not understood at present.
Surfactants are generally not ‘kind’ to skin; but the long his-
tory of using them in personal care products means that there
is substantial knowhow in dermatological alleviation.115 Another
disadvantage of surfactants – formulated as solid or liquid soaps
– is that they require washing by water. In many situations, such
as typically occurring in healthcare, this is either unavailable or
at least inconvenient. Here, alcohol-based hand sanitisers come
into their own. The WHO has a longstanding recommendation
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for alcohol-based hand sanitising liquids.116 The mechanism of
alcohol inactivation of enveloped viruses is no better elucidated
than is the case for surfactants. Moreover, the WHO formulations,
which contain 80% (v/v) ethanol or 75% (v/v) isopropyl alcohol
and . 2% glycerol in water, are low-viscosity Newtonian liquids.
Pouring and rubbing these on hands is inconvenient due to rapid
runoff; this presumably underlies the WHO’s recommendation to
surgeons that ‘a minimum of three applications are used, if not
more, for a period of 3-5 minutes’.
The solution is to gel the sanitising liquid. Many polymers are
available that will gel aqueous solutions at typically . 1% w/v,
but high alcohol content is a challenge, because under these con-
ditions, many if not most of the usual gelling agents are poorly
soluble. Some products specifically marketed for solubility at high
alcohol concentrations require careful pH adjustment for dissolu-
tion, and dissolution is a difficult subject that is far from fully
understood.117 Furthermore, at least in the early phase of the
COVID-19 crisis, the hand sanitiser industry faced a shortage of
the common polymers used in hydro-alcoholic hand gels, expos-
ing the desirability of finding new polymers that can be used as
alternatives. There is knowledge on some of the basic soft matter
science here, e.g. in the food literature.118 Note further that the
effect of these gelling agents on virus inactivation is unknown.
Alcohols also have their own disadvantage: they dissolve lipids
from the stratum corneum, the outmost layer of skin. This leads
to cracking. Discomfort apart, cracking opens up routes for the
entry of (non-respiratory!) pathogens. Repeated use over a long
period, necessary for many frontline workers, is therefore a prob-
lem. The soft matter science for alleviating this problem has
hardly started to develop. Previous work on the microfluidics
of skin61 and more recent advances in understanding stratum
corneum physics119 and elastocapillarity120 should form a good
basis for advances.
We should mention that nanoparticles are also possible an-
tiviral agents. One recent paper using designer binding ligands
on the surface of particles reports the generation of large forces
when viruses bind, leading to irreversible deformation.121 This
and other uses of nanotechnology-enabled approaches to com-
bating COVID-19 have recently been reviewed.7.
Our focus here is on the ‘outside’ story of respiratory viruses.
However, one aspect of the ‘inside’ story of such viruses should
be mentioned here, because it suggests a novel soft-matter-based
strategy for sanitising. It is known that moieties that promote
positive membrane curvature inhibit the fusion of viruses with
their host cells.122 This principle has been used to design poten-
tial new antiviral drugs.123 Perhaps such ‘fusion inhibitors’ may
also be used to decrease the infectivity of virions on fomite sur-
faces if a suitable means of application can be devised.
So far we have discussed hand sanitising. Many of the issues
raised are, however, also relevant to the disinfecting and clean-
ing of inanimate surfaces. For such surfaces, of course, a broader
range of chemical agents may be acceptable than for use on skin,
so that novel antiviral mechanisms may operate. The use of ultra-
violet (UV) radiation also becomes possible for fomite sanitising.
The recommendation124 is that the UVC band (below 280 nm).
Here, it is important to note that the both NaCl and proteins ab-
sorb strongly below 300 nm, so that viruses encrusted in salt and
mucin are likely somewhat protected against UVC.
3 Detection
Detecting infection has been at the forefront of public attention
since the beginning of the COVID-19 crisis. The topic can conve-
niently be discussed under the three headings of detecting genetic
material, whole viruses, and antibodies/antigens.
Much of the science of genetic material detection lies in the do-
main of molecular biology. Soft matter science may, however, still
make critical contributions. Thus, soft matter researchers have
long studied the microfluidics of complex fluids, which is used,
e.g., in making nucleic-acid or antibody based tests available as
‘point-of-care’ personal devices.125 Soft matter physics-inspired
approaches can also help improve nucleic acid-based methods
for detecting viruses. For example, a recent paper shows that
designing oligonucleotide probes to bind multivalently to target
bacterial DNA sequences should give better sensitivity and selec-
tivity,126 with potential application to RNA and SARS-CoV-2.
Detecting whole viruses can be done in many ways. Imaging
by electron microscopy is perhaps the most unambiguous, but re-
lies on perhaps the most expensive equipment. Another way to
proceed is by detecting the binding of virions to suitably function-
alised colloids by measuring the diffusive dynamics of the latter.
Thus, flu viruses can be detected under ideal laboratory condi-
tions through their binding to gold nanoparticles by monitoring
the latter’s diffusion using dynamic light scattering.127 However,
discriminating against false positives when virus hunting in com-
plex body fluids in a clinical setting will be more challenging.
Alteration in particle dynamics can also be used to detect the
binding of viral proteins (antigens) or antibodies produced by
infected individuals. However, these being small molecules, a
highly sensitive method is required. Holographic microscopy has
recently been demonstrated as being sensitive enough for this
task.128 One of the inventors of the technique has suggested that
it can be used for detecting antibodies from COVID-19 infection
or whole virions of SARS-CoV-2.129
For completeness, we mention the characterisation of the state
of aggregation of viruses. This can be done in a variety of ways,
some of which are familiar in soft matter science.130
4 Sustainability
The COVID-19 pandemic has many direct and indirect environ-
mental consequences.131,132 Some of these impacts are positive,
such as dramatically reduced NO2 pollution.133 The COVID-19
pandemic can be seen as an involuntary experiment to measure
the effect of global behavioural change on CO2 emission.134 The
results show that ‘social responses alone . . . would not drive the
deep and sustained reductions needed to reach net-zero emis-
sions’, but that ‘structural changes in the economic, transport or
energy systems’ will be needed.
Other impacts are negative.131,132 Of direct concern to soft
matter science is the increase in plastic waste associated with the
rise in hand sanitiser and one-off PPE usage. These trends, to-
gether with the sudden rise in consumer demand for take-away
and individually-packaged food products, mean that the COVID-
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19 pandemic contributes to the worsening of a parallel ‘plastic
pandemic’. The dramatic increase in the use of hand wipes has
also increased non-biodegradable and non-recyclable waste. Soft
matter science is a key player in the continued drive to find more
biodegradable plastics and other green materials135 for all of
these applications. On a related note, we have mentioned the
potential use of various nanotechnologies in the global response
to the COVID-19 (and future) pandemics. As these technolo-
gies are being developed, their environmental impact136 must be
carefully evaluated, for example, within a ‘responsible innovation’
framework.137,138
5 Discussion and conclusions
As the authors of a recent review2 have remarked in their con-
clusion, ‘[t]he COVID-19 pandemic has exposed significant scien-
tific gaps in our understanding of critical issues, ranging from the
transmission pathways of such respiratory diseases, to the strate-
gies to use for mitigating these transmissions.’ They have given
‘a fluid dynamicist’s perspective on important aspects of the prob-
lem.’ In this article, we have given a soft matter scientist’s per-
spective on the knowledge gaps revealed by COVID-19, some of
which are closely related to issues discussed in the fluid dynam-
ics essay. Given the importance of airborne transmission in the
spread of influenza, SARS-CoV-1, Middle East Respiratory Syn-
drome coronavirus and SARS-CoV-2 (see Zhang et al.4 and refer-
ences therein), progress in many of the areas we have identified
must be seen as urgent, not only for responding to the current
crisis, but also to anticipate future respiratory viral pandemics.
In some cases, progress in the soft matter science of COVID-
19 will depend on advances in other, allied, areas. For example,
much of soft matter research on mucin to date has used solu-
tions of reconstituted, purified proteins,10 which do not mimic
the complex microstructure of ‘the real thing’; neither do they re-
produce in vivo compositions, e.g., due to the absence of DNA.
Until recently, the only solution was to rely on ex vivo mucus sam-
ples obtained from relevant tissues.9 The availability of mucus-
secreting organs-on-a-chip139,140 therefore may offer new oppor-
tunities for soft matter work on viruses embedded in realistic mu-
cus droplets and films.
SARS-CoV-2 and other enveloped respiratory viruses are highly
infectious. In the UK’s list of approved classification of pathogens,
all members of the family Coronavirinae listed are classified into
Hazard Group (HG) 3, with the single exception of the human
coronavirus 229E, which is in HG 2. Most soft matter scientists
are unlikely to have access to their own HG 2 or 3 facilities.‖
However, in the spirit of much soft matter science applied to biol-
‖At the time of writing, the UK’s Advisory Committee on Harmful Pathogens has pro-
visionally classified SARS-CoV-2 into HG 3, so that all laboratory activities must
be carried out under Containment Level 3 rules. The CDC’s interim guidance
is consistent with this, but allows certain procedures (such as diagnostic tests)
to be carried out in Containment Level 2 laboratories. These are interim clas-
sifications. The reader who needs up to date information should consult the
websites of the respective agencies. The complete list of approved classification
of various pathogens are available in the UK from the Health and Safety Ex-
ecutive, https://www.hse.gov.uk/pubns/misc208.pdf, and corresponding
agencies in other countries.
ogy, it is possible to make progress on many of the research prob-
lems we have identified using model systems. The way a low con-
centration of nanoparticles may affect the fragmentation of vis-
coelastic liquid jets and sheets36,37 is a good example – it is likely
that results obtained using 100 nm negatively-charged synthetic
colloids should be applicable for understanding infected sneeze
ejecta; the more important issue here is likely the non-Newtonian
properties of the liquid matrix rather than realistic virions. An-
other area where model systems work may have high impact is
the study of patchy nanoparticles18 as viral surrogates. In this
context, we mention that nanoliposomes141 have been suggested
some time ago as credible mimics of enveloped viruses,142 so that
the construction of soft matter models of coronaviruses with vary-
ing degrees of sophistication (e.g. using lipid mixtures, including
some membrane proteins, etc.) based on these templates may be
a fruitful avenue to explore.
Translating advances in the areas we have described to prac-
tical solutions will require collaboration between soft matter sci-
entists and specialists from many disciplines. In particular, work
with virologists, epidemiologists and others in the medical com-
munity is needed to verify efficacy. On a purely practical level,
soft matter scientists who want to work on respiratory coron-
avirus will probably need to access Containment Level 3 labo-
ratory facilities operated by their microbiology colleagues. More-
over, engagement and collaboration with industry will ensure that
solutions can be scaled up to make a significant impact rapidly,
particularly for applications to the current pandemic.
Before offering some concluding remarks, we should emphasise
that we have not aimed to survey the areas that we have covered
with any degree of comprehensiveness – each area deserves a crit-
ical review of its own. There are also areas of soft matter science
relevant to the ‘outside’ story of the SARS-CoV-2 virus that we
have not been able to touch on; and we have quite deliberately
left out most of the ‘inside’ story. But what we have been able
to cover should hopefully be enough to convince the reader that
there are many immediate opportunities for applying soft mat-
ter science to help the global effort in combating the COVID-19
pandemic, and better prepare for viral pandemics in the future.
We offer two final remarks to conclude. First, the issues thrown
up by COVID-19 will not quickly disappear. On the contrary, they
are here to stay. We do not know how long SARS-CoV-2 will re-
main troublesome, but as of the time of writing, there is already
talk of ‘second waves’ around the world. In any case, there is now
heightened global awareness that we collectively are ill prepared
for pandemics.143 Research on the topics we have surveyed will
therefore remain timely for the foreseeable future (and beyond).
Secondly, and finally, we note that making progress in solving
many of the problems we have highlighted will yield new funda-
mental soft matter science. This direction of ‘knowledge transfer’,
from applications to basics, is not often emphasised in either po-
litical rhetoric or academic discourse,144 but is becoming increas-
ingly relevant, especially, perhaps, in the ‘new normal’ that will
emerge after the pandemic has run its course.
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